Ironwood Pharmaceuticals (IRWD) Earnings Analysis

Ironwood Pharmaceuticals (IRWD) next reports earnings on 2026-08-06, consensus EPS 0.32 USD. Last quarter (2026-05-07) it beat with EPS 0.24 USD vs 0.07 USD est (+242.9%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E 6.10.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does IRWD next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate0.32 USD
Revenue estimate0.12B

IRWD earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-070.24 USD0.07 USD+242.9%Beat
2026-02-25-0.01 USD0.02 USD-150%Miss
2025-11-100.24 USD0.09 USD+166.7%Beat
2025-02-270.02 USD0.1 USD-80%Miss
2024-11-070.02 USD0.08 USD-75%Miss

Beat rate: 2/5 (40%) over reported quarters with consensus data.

IRWD valuation and analyst view

Trailing P/E6.10
Trailing EPS0.62512 USD
Price / book-2.92
Dividend yield0.00%
Market cap0.63B
Analyst consensusHold (11 buy / 16 hold / 3 sell)
Avg price target4.55 USD

Related research pages

Frequently asked questions

When is Ironwood Pharmaceuticals (IRWD)'s next earnings date?

Ironwood Pharmaceuticals is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.32 USD and revenue estimate of 0.12B.

Did IRWD beat earnings last quarter?

In its 2026-05-07 report, IRWD posted EPS of 0.24 USD versus a 0.07 USD estimate — a beat of 242.9%.

What is IRWD's earnings track record?

Over the last 5 reported quarters with consensus data, IRWD beat estimates 2 times (40%).

What is IRWD's current P/E ratio and EPS?

IRWD trades at a trailing P/E of 6.10 on trailing EPS of 0.6251170075435452 USD.

What do analysts rate IRWD?

Analyst consensus is "Hold" across 30 ratings (0 strong buy, 11 buy, 16 hold, 3 sell, 0 strong sell). Average 12-month price target: 4.55 USD.